CA2320717C - Method for the treatment of diseases or disorders of the inner ear - Google Patents

Method for the treatment of diseases or disorders of the inner ear Download PDF

Info

Publication number
CA2320717C
CA2320717C CA002320717A CA2320717A CA2320717C CA 2320717 C CA2320717 C CA 2320717C CA 002320717 A CA002320717 A CA 002320717A CA 2320717 A CA2320717 A CA 2320717A CA 2320717 C CA2320717 C CA 2320717C
Authority
CA
Canada
Prior art keywords
inner ear
cells
p27kip1
nucleic acid
regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002320717A
Other languages
English (en)
French (fr)
Other versions
CA2320717A1 (en
Inventor
Hubert Lowenheim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sound Pharmaceuticals Inc
Original Assignee
Sound Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sound Pharmaceuticals Inc filed Critical Sound Pharmaceuticals Inc
Publication of CA2320717A1 publication Critical patent/CA2320717A1/en
Application granted granted Critical
Publication of CA2320717C publication Critical patent/CA2320717C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002320717A 1998-02-23 1999-02-23 Method for the treatment of diseases or disorders of the inner ear Expired - Fee Related CA2320717C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19807426A DE19807426A1 (de) 1998-02-23 1998-02-23 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
DE19807426.3 1998-02-23
PCT/EP1999/001153 WO1999042088A2 (de) 1998-02-23 1999-02-23 Verfahren zur behandlung von erkrankungen oder störungen des innenohrs

Publications (2)

Publication Number Publication Date
CA2320717A1 CA2320717A1 (en) 1999-08-26
CA2320717C true CA2320717C (en) 2009-03-24

Family

ID=7858563

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002320717A Expired - Fee Related CA2320717C (en) 1998-02-23 1999-02-23 Method for the treatment of diseases or disorders of the inner ear

Country Status (11)

Country Link
US (1) US7087581B1 (cg-RX-API-DMAC7.html)
EP (1) EP1056467B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002503687A (cg-RX-API-DMAC7.html)
AT (1) ATE250936T1 (cg-RX-API-DMAC7.html)
AU (1) AU763868B2 (cg-RX-API-DMAC7.html)
CA (1) CA2320717C (cg-RX-API-DMAC7.html)
DE (2) DE19807426A1 (cg-RX-API-DMAC7.html)
DK (1) DK1056467T3 (cg-RX-API-DMAC7.html)
ES (1) ES2211055T3 (cg-RX-API-DMAC7.html)
PT (1) PT1056467E (cg-RX-API-DMAC7.html)
WO (1) WO1999042088A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325198A1 (en) 1999-06-01 2011-05-25 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
EP1307542A2 (en) * 2000-07-11 2003-05-07 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
AU2003268741B2 (en) 2002-10-02 2009-06-11 Anges Mg, Inc. Drug for auditory dysfunction
DE60323876D1 (de) * 2002-12-17 2008-11-13 Centre Nat Rech Scient Verwendung von purinderivaten zur induktion der differenzierung überzähliger haarzellen und deiter-zellen im entwickelnden corti-organ zur behandlung von taubheit
US8431692B2 (en) * 2008-06-06 2013-04-30 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
DE102010007281A1 (de) 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
RU2480195C1 (ru) * 2011-11-02 2013-04-27 Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") Способ лечения заболеваний внутреннего уха
EP2802657B1 (en) 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
US20150079110A1 (en) * 2012-03-05 2015-03-19 Wake Forest University Health Sciences Regeneration of inner ear cells
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
AU727037B2 (en) 1995-11-13 2000-11-30 Cenes Pharmaceuticals, Inc. Methods of treating disorders of non-visual sensory epithelia
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
WO1998000014A1 (en) * 1996-06-28 1998-01-08 The Regents Of The University Of California Transformation and genetherapy of cells of the inner ear
WO1998013048A1 (en) 1996-09-27 1998-04-02 Trustees Of The University Of Pennsylvania Novel methods for inducing proliferation in auditory receptor epithelium
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product

Also Published As

Publication number Publication date
US7087581B1 (en) 2006-08-08
AU763868B2 (en) 2003-07-31
DE19807426A1 (de) 1999-10-14
AU2928199A (en) 1999-09-06
EP1056467A2 (de) 2000-12-06
DK1056467T3 (da) 2004-02-09
ATE250936T1 (de) 2003-10-15
ES2211055T3 (es) 2004-07-01
JP2002503687A (ja) 2002-02-05
EP1056467B1 (de) 2003-10-01
DE59907195D1 (de) 2003-11-06
WO1999042088A2 (de) 1999-08-26
PT1056467E (pt) 2004-02-27
CA2320717A1 (en) 1999-08-26
WO1999042088A3 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
Kole et al. Activating transcription factor 3 (ATF3) protects retinal ganglion cells and promotes functional preservation after optic nerve crush
RU2288718C2 (ru) Лекарственные средства, содержащие ингибиторы человеческой h-sgk киназы, контролирующей клеточный объем
Yamanaka et al. Orexins activate histaminergic neurons via the orexin 2 receptor
US9382313B2 (en) Modulation of synaptic maintenance
Jørgensen et al. Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo
US7087581B1 (en) Method for the treatment of diseases or disorders of the inner ear
Akil et al. Virally mediated overexpression of glial-derived neurotrophic factor elicits age-and dose-dependent neuronal toxicity and hearing loss
WO2024251289A1 (en) Use of kinase domain m7ck of trpm7 in preparation of drug for treating alzheimer's disease
Carlton et al. A critical period of prehearing spontaneous Ca2+ spiking is required for hair‐bundle maintenance in inner hair cells
Zhang et al. Functional optic tract rewiring via subtype-and target-specific axonal regeneration and presynaptic activity enhancement
CN111253492B (zh) 一种透脑性多肽及其在制备防治老年痴呆药物中应用
Bohuslavova et al. Pax2-Islet1 transgenic mice are hyperactive and have altered cerebellar foliation
Kustermann et al. Survival, excitability, and transfection of retinal neurons in an organotypic culture of mature zebrafish retina
Crook et al. Surveying the landscape of Huntington's disease mechanisms, measurements, and medicines
Bitsche et al. Neurotrophic receptors as potential therapy targets in postnatal development, in adult, and in hearing loss-affected inner ear
Kelley Cellular commitment and differentiation in the cochlea: potential advances using gene transfer
Petrova et al. Protrudin functions as a scaffold in the endoplasmic reticulum to support axon regeneration in the adult central nervous system
KR101766441B1 (ko) 헌팅틴 유전자의 뇌 시공간 특이적 발현 방법 및 이를 이용한 동물 모델
Qamar Creating an in vivo model of Progressive Supranuclear Palsy
Langlet et al. Tanycyte-mediated synapse pruning shapes hypothalamic circuits controlling metabolism
PANE et al. The Upper Limb Cardiopulmonary Exercise Test in Friedrich Ataxia Patients
Brooks Pou3f4-Expressing Otic Mesenchyme Cells: A Novel Influence for Cochlear Spiral Ganglion Neuron Survival
Chiara et al. Neuronal hemoglobin induces α-synuclein cleavage and loss of dopaminergic neurons
Jones Oncomodulin Alters the Ca2+-Regulating Network in Cochlear Outer Hair Cells.
WO2025151665A1 (en) Methods and composition for modulating a bioelectric pattern

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed